Immediate Impact

1 by Nobel laureates 3 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
2 intermediate papers

Works of Guido Parvis being referenced

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
1998

Author Peers

Author Last Decade Papers Cites
Guido Parvis 233 143 193 24 426
Dipti Patel‐Donnelly 212 130 193 27 421
GJ van Ommen 254 155 156 13 492
Irene Ricca 219 191 194 28 497
Jacob Haaber Christensen 222 235 190 48 484
Sabela Bobillo 253 116 188 39 404
David H. Vesole 195 142 190 30 432
Junji Hiraga 256 137 181 17 447
Manfred Welslau 325 223 295 26 483
Nilima Parry‐Jones 309 308 166 19 485
Vaishalee P. Kenkre 250 200 243 36 423

All Works

Loading papers...

Rankless by CCL
2026